<header id=058487>
Published Date: 2022-01-09 16:27:56 EST
Subject: PRO/ALL> New in IJID (01): December 2021
Archive Number: 20220109.8700756
</header>
<body id=058487>
NEW IN INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (01): DECEMBER 2021
***********************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org

Date: December 2021
Source: IJID [edited]
https://www.ijidonline.com/


Coronavirus (COVID-19) collection
-----------------------------------------
Clinical
--------
Clinical characteristics of patients with coronavirus disease (COVID-19): preliminary baseline report of Japan COVID-19 task force, a nationwide consortium to investigate host genetics of COVID-19.
Tanaka H et al.
Int J Infect Dis. 2021;113:74-81
https://doi.org/10.1016/j.ijid.2021.09.070

Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2 virus.
Savva D et al.
Int J Infect Dis. 2021;113:233-235
https://doi.org/10.1016/j.ijid.2021.09.066

Thromboembolic and bleeding events in ICU patients with COVID-19: results from a Brazilian tertiary hospital.
Guerra Soares Brandao AA et al.
Int J Infect Dis. 2021;113:236-242
https://doi.org/10.1016/j.ijid.2021.10.020

Treatment
----------
Real world long-term assessment of the efficacy of tocilizumab in patients with COVID-19: results from a large de-identified multicenter electronic health record dataset in the United States.
Nigo M et al.
Int J Infect Dis. 2021;113:148-154
https://doi.org/10.1016/j.ijid.2021.09.067

Diagnostics
------------
Rapid antibody testing for SARS-CoV-2 vaccine response in pediatric healthcare workers.
Heyming TW et al.
Int J Infect Dis. 2021;113:1-6
https://doi.org/10.1016/j.ijid.2021.09.065

SARS-CoV-2 variants of concern are associated with lower RT-PCR amplification cycles between January and March 2021 in France.
Roquebert B et al.
Int J Infect Dis. 2021;113:12-14
https://doi.org/10.1016/j.ijid.2021.09.076

Comparison of Allplex SARS-CoV-2 assay, easy SARS-CoV-2 WE and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
Sberna G et al.
Int J Infect Dis. 2021;113:113-115
https://doi.org/10.1016/j.ijid.2021.09.069

Rapid screening for SARS-CoV-2 VOC-alpha (202012/01, B.1.1.7) using the Allplex SARS-CoV-2 / FluA / FluB / RSV assay.
Giovacchini N et al.
Int J Infect Dis. 2021;113:207-209
https://doi.org/10.1016/j.ijid.2021.10.005

Evaluation of Panbio rapid antigen test for SARS-CoV-2 in symptomatic patients and their contacts: a multicenter study.
Thirion-Romero I et al.
Int J Infect Dis. 2021;113:218-224
https://doi.org/10.1016/j.ijid.2021.10.027

T-cell receptor repertoires as potential diagnostic markers for patients with COVID-19.
Hou X et al.
Int J Infect Dis. 2021;113: 308-317
https://doi.org/10.1016/j.ijid.2021.10.033

Performance and cost-effectiveness of a pooled-testing strategy for SARS-CoV-2 using real-time polymerase chain reaction in Uganda.
Bogere N et al.
Int J Infect Dis. 2021;113: 355-358
https://doi.org/10.1016/j.ijid.2021.10.038

Performance of the T-SPOT COVID test for detecting SARS-CoV-2-responsive T cells.
Kruse M et al.
Int J Infect Dis. 2021;113: 155-161
https://doi.org/10.1016/j.ijid.2021.09.073

Pathology and immunology
----------------------------
Persistent IgG anti-cardiolipin autoantibodies are associated with post-COVID syndrome.
Bertin D et al.
Int J Infect Dis. 2021;113:23-25
https://doi.org/10.1016/j.ijid.2021.09.079

Clinical investigation of intestinal fatty acid-binding protein (I-FABP) as a biomarker of SARS-CoV-2 infection.
Saia RS et al.
Int J Infect Dis. 2021;113:82-86
https://doi.org/10.1016/j.ijid.2021.09.051

Transient increase of plasma HIV RNA after COVID-19 vaccination with mrna-1272.
Bozzi G et al.
Int J Infect Dis. 2021;113:125-126
https://doi.org/10.1016/j.ijid.2021.10.021

Coronavirus disease-19 and the gut-lung axis.
Zhou D et al.
Int J Infect Dis. 2021;113: 300-307
https://doi.org/10.1016/j.ijid.2021.09.013

Models for COVID-19 early cardiac pathology following SARS-CoV-2 infection.
Fremont-Smith M et al.
Int J Infect Dis. 2021;113: 331-335
https://doi.org/10.1016/j.ijid.2021.09.052

Epidemiology
----------------
Infection fatality ratio and case fatality ratio of COVID-19.
Luo G et al.
Int J Infect Dis. 2021;113:43-46
https://doi.org/10.1016/j.ijid.2021.10.004

Study of perinatal transmission of SARS-CoV-2 in a Mexican public hospital.
Ramirez-Rosas A et al.
Int J Infect Dis. 2021;113:225-232
https://doi.org/10.1016/j.ijid.2021.10.006

Hospital infection control
---------------------------
COVID-19 and antimicrobial stewardship: lessons learned, best practices and future implications.
Pierce J et al.
Int J Infect Dis. 2021;113:103-108
https://doi.org/10.1016/j.ijid.2021.10.001

SARS-CoV-2 seropositivity among pediatric health-care personnel just after the 1st peak of pandemic: a nationwide surveillance.
Oygar PD et al.
Int J Infect Dis. 2021;113:184-189
https://doi.org/10.1016/j.ijid.2021.09.054

Public health
-------------
The Global Health Security Index is not predictive of vaccine rollout responses among OECD countries.
Khalifa BA et al.
Int J Infect Dis. 2021;113:7-11
https://doi.org/10.1016/j.ijid.2021.09.034

Impact of contact tracing, respect of isolation, and lockdown in reducing the number of cases infected with COVID-19: Case study: Tunisia's response from 22 Mar to 4 May 2020.
Saidi O et al.
Int J Infect Dis. 2021;113: 26-33
https://doi.org/10.1016/j.ijid.2021.02.010

Predicting the effective reproduction number of COVID-19: inference using human mobility, temperature, and risk awareness.
Jung S et al.
Int J Infect Dis. 2021;113:47-54
https://doi.org/10.1016/j.ijid.2021.10.007

COVID-19 as a leading cause of hospitalizations with death in the Brazilian Public Health System in 2020.
Zimmermann IR et al.
Int J Infect Dis. 2021;113:162-165
https://doi.org/10.1016/j.ijid.2021.09.077

Practice of COVID-19 preventive measures and risk of acute respiratory infections: a longitudinal study in students from 95 countries.
Masai AN et al.
Int J Infect Dis. 2021;113:168-174
https://doi.org/10.1016/j.ijid.2021.10.017

Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Mogadishu, Somalia.
Warsame A et al.
Int J Infect Dis. 2021;113:190-199
https://doi.org/10.1016/j.ijid.2021.09.049

Examining SARS-CoV-2 interventions in residential colleges using an empirical network.
Hambridge HL et al.
Int J Infect Dis. 2021;113: 325-330
https://doi.org/10.1016/j.ijid.2021.10.008

Emerging socioeconomic disparities in COVID-19-related deaths during the 2nd pandemic wave in Germany.
Hoebel J et al.
Int J Infect Dis. 2021;113:344-346
https://doi.org/10.1016/j.ijid.2021.10.037

Geospatial variability in excess death rates during the COVID-19 pandemic in Mexico: examining socio demographic, climate and population health characteristics.
Dahal S et al.
Int J Infect Dis. 2021;113: 347-354
https://doi.org/10.1016/j.ijid.2021.10.024

Vaccines
---------
Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.
Cucunawangsih C et al.
Int J Infect Dis. 2021;113: 15-17
https://doi.org/10.1016/j.ijid.2021.09.078

A case of varicella zoster virus meningitis following BNT162b2 mRNA COVID-19 vaccination in an immunocompetent patient.
Maruki T et al.
Int J Infect Dis. 2021;113:55-57
https://doi.org/10.1016/j.ijid.2021.09.055

Comparison of an inactivated COVID-19 vaccine-induced antibody response with concurrent natural COVID-19 infection.
Azak E et al.
Int J Infect Dis. 2021;113:58-64
https://doi.org/10.1016/j.ijid.2021.09.060

COVID-19 vaccination: effective utilization of low dead space (LDS) syringes.
Shinozuka J et al.
Int J Infect Dis. 2021;113:90-92
https://doi.org/10.1016/j.ijid.2021.09.068

Measuring the Impact of single dose of ChAdOx1 nCoV-19 coronavirus vaccine (recombinant) on hospital stay, ICU requirement, and mortality outcome in a tertiary care centre.
Desai A et al.
Int J Infect Dis. 2021;113: 282-287
https://doi.org/10.1016/j.ijid.2021.10.032

The role of COVID-19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical year medical student in Indonesia.
Heriyanto RS et al.
Int J Infect Dis. 2021;113: 336-338
https://doi.org/10.1016/j.ijid.2021.10.009

Case reports
-------------
Bilateral uveitis after inoculation with COVID-19 vaccine: a case report.
Pan L et al.
Int J Infect Dis. 2021;113:116-118
https://doi.org/10.1016/j.ijid.2021.09.075

Heart failure secondary to myocarditis after SARS-CoV-2 reinfection: a case report.
Riedel PG et al.
Int J Infect Dis. 2021;113:175-177
https://doi.org/10.1016/j.ijid.2021.10.031

Sudden sensorineural hearing loss after COVID-19 vaccination.
Jeong J et al.
Int J Infect Dis. 2021;113: 341-343
https://doi.org/10.1016/j.ijid.2021.10.025

Non-COVID-19 collection
-----------------------------
Bacterial infections
--------------------
Impact of beta-lactamase detection reagent on rapid diagnosis of ESBL-producing pathogens using urine samples of patients with gram-negative bacteriuria.
Yoshimura J et al.
Int J Infect Dis. 2021;113: 18-22
https://doi.org/10.1016/j.ijid.2021.09.059

Etiology of granulomatous lobular mastitis based on metagenomic next-generation sequencing.
Jiaxin B et al.
Int J Infect Dis. 2021;113: 243-250
https://doi.org/10.1016/j.ijid.2021.10.019

Predictors and outcomes of diabetic foot ulcer infection with ESBL-producing bacteria in a large tertiary center.
Leibovitch M et al.
Int J Infect Dis. 2021;113: 318-324
https://doi.org/10.1016/j.ijid.2021.10.016

Antimicrobial activities of ceftazidime-avibactam, ceftolozane-tazobactam, imipenem-relebactam, and meropenem-vaborbactam against _Pseudomonas aeruginosa_ from patients with skin and soft tissue infections.
Sader HS et al.
Int J Infect Dis. 2021;113: 279-281
https://doi.org/10.1016/j.ijid.2021.10.022

Tuberculosis
--------------
Cost-effectiveness of video-observed therapy for ambulatory management of active tuberculosis during COVID-19 pandemic in a high-income country.
Fekadu G et al.
Int J Infect Dis. 2021;113:271-278
https://doi.org/10.1016/j.ijid.2021.10.029

Lack of latent tuberculosis screening and delay in anti-retroviral therapy initiation in HIV-TB co-infection: an 11-year study in an intermediate TB-burden country.
Teng VYM et al.
Int J Infect Dis. 2021;113: 178-183
https://doi.org/10.1016/j.ijid.2021.09.048

Tuberculosis treatment incompletion in patients with lung cancer: occurrence and predictors.
Lee C-S et al.
Int J Infect Dis. 2021;113: 200-206
https://doi.org/10.1016/j.ijid.2021.09.072

Who is more likely to return for TB test results? A survey at 3 high-burden primary healthcare facilities in Cape Town, South Africa .
Burger R et al.
Int J Infect Dis. 2021;113:259-267
https://doi.org/10.1016/j.ijid.2021.10.015

Risk groups of developing active tuberculosis in liver transplant recipients in a tuberculosis endemic area: risk stratification by chest image and interferon gamma release assay.
Kim S-H et al.
Int J Infect Dis. 2021;113: 359-366
https://doi.org/10.1016/j.ijid.2021.10.043

Viral infections
----------------
Characteristics and therapy of enteroviral encephalitis: case report and systematic literature review.
Wagner JN et al.
Int J Infect Dis. 2021;113: 93-102
https://doi.org/10.1016/j.ijid.2021.10.002

Prevalence of resistance-associated substitutions and phylogenetic analysis of hepatitis C virus infection in Russia.
Isakov V et al.
Int J Infect Dis. 2021;113: 36-42
https://doi.org/10.1016/j.ijid.2021.09.041

Chikungunya viruses containing the A226V mutation detected retrospectively in Cameroon form a new geographical subclade.
Agbodzi B et al.
Int J Infect Dis. 2021;113: 65-73
https://doi.org/10.1016/j.ijid.2021.09.058

Nationwide vector surveillance on Zika and dengue did not indicate transmission of the American lineage-pandemic Zika virus in India.
Kumar NP et al.
Int J Infect Dis. 2021;113: 119-124
https://doi.org/10.1016/j.ijid.2021.09.074

Association between hemorrhagic fever with renal syndrome and cancers.
Yi YJ et al.
Int J Infect Dis. 2021;113: 127-135
https://doi.org/10.1016/j.ijid.2021.10.014

Post-exposure prophylaxis following high-risk contact with Ebola virus, using immunotherapies with monoclonal antibodies, in the eastern DRC: an emergency use program.
Jaspard M et al.
Int J Infect Dis. 2021;113: 166-167
https://doi.org/10.1016/j.ijid.2021.09.053

HIV
---
Antiretroviral therapy use in selected countries in Latin America during 2013-2017: results from the Latin American workshop in HIV study group.
Zitko P et al.
Int J Infect Dis. 2021;113: 288-296
https://doi.org/10.1016/j.ijid.2021.09.047

Parasitic infections
-------------------
COVID-19 pandemic causes increased clinic visits with diagnosis of tegumentary leishmaniasis in Brazil in 2020.
Andrade MC et al.
Int J Infect Dis. 2021;113:87-89
https://doi.org/10.1016/j.ijid.2021.10.003

Comparative effect of dihydroartemisinin-piperaquine versus artemether-lumefantrine on gametocyte clearance and hemoglobin recovery in children with uncomplicated _Plasmodium falciparum_ malaria in Africa: a systematic review and meta-analysis of randomized control trials.
Assefa DG et al.
Int J Infect Dis. 2021;113: 136-147
https://doi.org/10.1016/j.ijid.2021.10.013

Differentiation of acquired immune deficiency syndrome-related primary central nervous system lymphoma from cerebral toxoplasmosis using susceptibility-weighted imaging and contrast-enhanced 3D-T1WI.
Li J et al.
Int J Infect Dis. 2021;113: 251-258
https://doi.org/10.1016/j.ijid.2021.10.023

Case reports
------------
Suboptimal drug exposure leads to selection of different subpopulations of ceftazidime/avibactam-resistant KPC-producing _Klebsiella pneumoniae_ in a critically ill patient.
Gaibani P et al.
Int J Infect Dis. 2021;113: 213-217
https://doi.org/10.1016/j.ijid.2021.10.028

A couple returning from Peru with persistent fever: think of histoplasmosis.
Van Den Broucke S et al.
Int J Infect Dis. 2021;113: 268-270
https://doi.org/10.1016/j.ijid.2021.10.039

Medical imagery
-----------------
Painful and swollen tongue: mucosal leishmaniasis due to _Leishmania infantum_.
Chong G-L M et al.
Int J Infect Dis. 2021;113: 109-112
https://doi.org/10.1016/j.ijid.2021.09.071

Paraplegia via hematogenous dissemination of _Cunninghamella elegans_ (mucormycosis) after hematopoietic stem cell transplantation.
Shirane S et al.
Int J Infect Dis. 2021;113: 210-212
https://doi.org/10.1016/j.ijid.2021.10.018

In vivo reflectance confocal microscopy in patients with chromoblastomycosis.
Borges JR et al.
Int J Infect Dis. 2021;113: 297-299
https://doi.org/10.1016/j.ijid.2021.09.030

Generalized tinea corporis caused by _Trichophyton verrucosum_ misdiagnosed as allergic dermatitis and erythema annulare in an adult.
Liu X et al.
Int J Infect Dis. 2021;113: 339-340
https://doi.org/10.1016/j.ijid.2021.10.049

Corrigendum
Corrigendum to 'Worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.'
Tsikala-Vafea M et al.
Int J Infect Dis. 2021;113: 34-35
https://doi.org/10.1016/j.ijid.2021.08.046

--
Communicated by:
ProMED

[Happy New Year to our readers and authors from the editors.]
See Also
2021
----
New in IJID (11): November 2021: 20211205.8700079
New in IJID (10): October 2021: 20211107.8699506
New in IJID (09): September 2021: 20211007.8698901
New in IJID (08): August 2021: 20210907.8651803
New in IJID (07): July 2021 20210812.8580841
New in IJID (06): June 2021 20210722.8536790
New in IJID (05): May 2021 20210516.8364910
New in IJID (04): April 2021 120210421.8319851
New in IJID (03): March 2021 20210316.8250191
New in IJID (02): February 2021 20210210.8182520
New in IJID (01): January 2021 20210114.8102611
2020
----
New in IJID (12): December 2020 20201209.8005250
.................................................ep/tw/jh
</body>
